Par Hyare
2021
In 2021, Par Hyare earned a total compensation of $421.8K as Interim Chief Executive Officer at Sunesis Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $116,668 |
|---|---|
| Salary | $55,129 |
| Other | $250,002 |
| Total | $421,799 |
Hyare received $250K in other compensation, accounting for 59% of the total pay in 2021.
Hyare also received $116.7K in non-equity incentive plan and $55.1K in salary.
Rankings
In 2021, Par Hyare's compensation ranked 11,075th out of 12,415 executives tracked by ExecPay. In other words, Hyare earned more than 10.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,075 out of 12,415 | 11th |
Division Manufacturing | 4,887 out of 5,505 | 11th |
Major group Chemicals And Allied Products | 2,181 out of 2,375 | 8th |
Industry group Drugs | 1,941 out of 2,096 | 7th |
Industry Pharmaceutical Preparations | 1,438 out of 1,546 | 7th |
Source: SEC filing on April 27, 2022.
Hyare's colleagues
We found three more compensation records of executives who worked with Par Hyare at Sunesis Pharmaceuticals in 2021.